All practice questions

8270 questions

Question 1701Question →

Match each clinical scenario describing a medication-induced renal, electrolyte, or acid-base abnormality to the corresponding causative pharmacological agent.

Click a left item, then click its matching right item

Items

During the course of antimicrobial therapy for a skin and soft tissue infection, a patient demonstrates an isolated rise in serum creatinine from 0.9 mg/dL0.9 \text{ mg/dL} to 1.6 mg/dL1.6 \text{ mg/dL}. Concurrent laboratory testing reveals a serum potassium of 5.4 mEq/L5.4 \text{ mEq/L}, though the estimated glomerular filtration rate remains strictly within normal limits.
Following initiation of intravenous antifungal therapy for an invasive mycosis, a patient develops profound lower extremity cramping. Biochemical evaluation shows a serum potassium of 2.8 mEq/L2.8 \text{ mEq/L}, a non-anion gap metabolic acidosis, and an inappropriately elevated urine pH of 6.86.8.
A patient managed pharmacologically for idiopathic intracranial hypertension reports progressive fatigue. A basic metabolic panel confirms a non-anion gap metabolic acidosis with a serum bicarbonate of 17 mEq/L17 \text{ mEq/L}, while urinalysis demonstrates an appropriately acidic urine pH of 5.25.2.
While receiving long-term maintenance therapy for a mood disorder, a patient complains of unremitting thirst and excessive urination. Serum sodium is elevated at 152 mEq/L152 \text{ mEq/L}, and urine osmolality is 115 mOsm/kg115 \text{ mOsm/kg}, which fails to increase significantly following the administration of exogenous desmopressin.

Matches

Show answer & explanation

Answer

The correct pairings identify Trimethoprim-sulfamethoxazole for the isolated creatinine elevation with hyperkalemia, Amphotericin B for the Type 1 RTA presentation, Acetazolamide for the Type 2 RTA presentation, and Lithium carbonate for the nephrogenic diabetes insipidus presentation.
Each pharmacological agent possesses a distinct pathophysiological mechanism affecting the renal tubules: Trimethoprim blocks both creatinine secretion and ENaC channels; Amphotericin B creates pores in the distal tubule causing a Type 1 RTA; Acetazolamide inhibits proximal carbonic anhydrase causing a Type 2 RTA; and Lithium induces ADH resistance at the collecting duct, causing nephrogenic DI.

Step-by-Step Solution

1
Analyze the scenario with isolated creatinine rise and hyperkalemia but normal eGFR.
Identifies tubular secretion blockade and distal ENaC inhibition, consistent with trimethoprim-sulfamethoxazole use.
Differentiating pseudo-renal failure from true acute kidney injury is essential when managing patients on specific antimicrobials.
2
Evaluate the non-anion gap metabolic acidosis accompanied by severe hypokalemia and a high urine pH (> 5.5).
Classifies the disorder as Type 1 (distal) renal tubular acidosis, a known toxicity of amphotericin B.
The inability to excrete hydrogen ions distally results in an inappropriately alkaline urine despite systemic acidosis.
3
Evaluate the non-anion gap metabolic acidosis with intact distal acidification (urine pH < 5.5).
Identifies Type 2 (proximal) renal tubular acidosis, an expected effect of acetazolamide therapy.
Acetazolamide wastes bicarbonate proximally, but because the distal tubule is unharmed, the urine can eventually be acidified.
4
Analyze the ADH-resistant polyuria and hypernatremia.
Confirms a diagnosis of nephrogenic diabetes insipidus, which is a classic adverse effect of chronic lithium therapy.
The lack of response to exogenous desmopressin localizes the defect to the renal collecting duct rather than central ADH release.

Key Concept

Pathophysiology and identification of drug-induced nephrotoxicity and distinct acid-base/electrolyte derangements.
Question 1702Question →

A 72-year-old woman presents to the emergency department with a 2-day history of right-sided temporal headache, jaw pain with chewing, and scalp tenderness. This morning, she experienced a 10-minute episode of painless visual loss in her right eye that has since resolved. Her temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 130/80 mmHg130/80\text{ mmHg}, and pulse is 84/min84/\text{min}. Physical examination reveals a prominent, tender right temporal artery with diminished pulsation. Laboratory studies show an erythrocyte sedimentation rate (ESR) of 105 mm/h105\text{ mm/h}. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Administer high-dose intravenous methylprednisolone, then perform a temporal artery biopsy, then transition to high-dose oral prednisone, and finally initiate a gradual glucocorticoid taper.
The patient's presentation is classic for giant cell arteritis (GCA) complicated by transient ischemic vision loss (amaurosis fugax). Because GCA can cause rapid, irreversible blindness via anterior ischemic optic neuropathy, the absolute first priority is to administer high-dose intravenous methylprednisolone. Corticosteroids must never be delayed for diagnostic testing. Once therapy is initiated, a temporal artery biopsy should be performed (usually within 1 to 2 weeks) to confirm the diagnosis, as the histologic signs of arteritis remain present for several days to weeks after starting steroids. Following a short course of intravenous therapy, the patient is transitioned to high-dose oral prednisone. Finally, once clinical symptoms have completely resolved and the ESR has normalized, a very gradual tapering of the oral steroids is initiated over several months to minimize steroid-induced adverse effects while preventing disease relapse.

Step-by-Step Solution

1
Identify the primary diagnosis and its severity based on the clinical presentation.
The patient has giant cell arteritis complicated by amaurosis fugax (transient vision loss), which is an acute ischemic complication.
Recognizing ischemic complications dictates the urgency and route of corticosteroid administration.
2
Determine the immediate next best step in management.
Administer intravenous methylprednisolone.
Immediate high-dose IV steroids are required to prevent permanent blindness. Delaying treatment for diagnostic testing is contraindicated.
3
Determine the timing of the definitive diagnostic test.
Perform a temporal artery biopsy.
Biopsy is the gold standard and should be done within 1-2 weeks of starting steroids, as diagnostic histologic features persist during early treatment.
4
Identify the long-term management strategy.
Transition to oral prednisone, followed eventually by a gradual taper.
IV steroids are typically given for a short duration, followed by oral maintenance. Once symptoms and ESR normalize, a slow taper prevents both steroid toxicity and disease relapse.

Key Concept

In giant cell arteritis with ischemic complications (e.g., vision changes), immediate high-dose intravenous corticosteroids are required to prevent blindness, taking precedence over obtaining a temporal artery biopsy.
Question 1703Question →

A 19-year-old male college student is brought to the emergency department by paramedics after experiencing a generalized tonic-clonic seizure that lasted 2 minutes. His roommate reports that the patient had complained of a severe headache, nausea, and high fever for the past 12 hours. His temperature is 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), blood pressure is 98/6098/60 mmHg, and heart rate is 124124/min. On physical examination, the patient is lethargic, postictal, and mildly confused. Pronounced nuchal rigidity is present. A non-blanching petechial rash is observed on his bilateral lower extremities.

Arrange the following next steps in management in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately administer empiric intravenous antibiotics and dexamethasone, perform a non-contrast head CT scan, and finally perform a lumbar puncture.
The standard of care for suspected bacterial meningitis requires the rapid initiation of therapy. While a lumbar puncture (LP) is the definitive diagnostic test, certain patients are at high risk for cerebral herniation and require a head CT before the LP. The Infectious Diseases Society of America (IDSA) guidelines require a CT before LP in patients with immunocompromise, a history of CNS disease, new-onset seizures, papilledema, altered level of consciousness, or focal neurologic deficits. Because this patient has a new-onset seizure and altered mental status, the sequence must be: 1) Blood cultures, 2) Empiric antibiotics and dexamethasone, 3) Head CT, and 4) Lumbar puncture. This guarantees that life-saving treatment is not delayed by the time required to obtain and interpret neuroimaging.

Step-by-Step Solution

1
Recognize the clinical presentation and identify 'red flag' indications.
The patient has signs of bacterial meningitis (fever, headache, nuchal rigidity, petechial rash) along with indications for a head CT before LP (new-onset seizure and altered mental status).
Identifying red flags dictates the diagnostic and therapeutic pathway, specifically indicating the need for neuroimaging before safely accessing the subarachnoid space.
2
Determine the first immediate action upon arrival.
Obtain blood cultures.
Blood cultures are rapid and should always be drawn prior to the administration of any antimicrobials to ensure the highest yield for identifying the causative pathogen.
3
Decide the timing of empiric antimicrobial therapy.
Administer empiric intravenous antibiotics and dexamethasone immediately.
Because the patient must go to the CT scanner before the LP, definitive CSF evaluation will be delayed. To prevent mortality and neurologic deficits, empiric therapy must be given immediately after blood cultures, without waiting for the CT or LP results.
4
Determine the sequence of imaging and invasive testing.
Perform a non-contrast head CT, followed by a lumbar puncture.
The CT scan is necessary to rule out mass lesions and prevent cerebral herniation. Once mass effect is ruled out, the LP is performed to obtain CSF for definitive analysis.

Key Concept

In patients with suspected bacterial meningitis who have indications for a head CT prior to lumbar puncture (e.g., new-onset seizure, altered mental status, papilledema, immunocompromise), empiric antibiotics and dexamethasone must be administered immediately after blood cultures are drawn, before sending the patient for imaging.
Question 1704Question →

An otherwise healthy 36-month-old girl is evaluated via a telehealth consultation for a routine health maintenance visit. Her parents express anxiety regarding her developmental progress compared to other children in her playgroup. Specifically, they note that she cannot hop on one foot or draw a cross on paper. During the video observation, the physician notes the child pedaling a small tricycle across the room and walking up a set of stairs using alternating feet. When given crayons, she successfully copies a circle but simply scribbles when attempting to copy a square. She answers the physician's questions using three-word sentences, and the physician easily understands approximately 75% of what she says. She correctly states her name and age when asked. Based on this presentation, which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Provide parental education that these findings reflect normal maturation

Answer

Provide parental education that these findings reflect normal maturation
The patient exhibits completely normal developmental milestones for a 3-year-old (36 months). At age 3, a child is expected to ride a tricycle, walk up stairs with alternating feet (gross motor), copy a circle, use utensils (fine motor), speak in 3-word sentences with 75% intelligibility (language), and know their age and gender (social). The skills the parents are concerned about—hopping on one foot and copying a cross—are milestones expected at age 4 (48 months). Because the child is developing normally, the most appropriate next step is to educate and reassure the parents.

Step-by-Step Solution

1
Evaluate the patient's gross motor skills against standard milestones.
The patient pedals a tricycle and alternates feet on stairs, which are 3-year milestones. Her inability to hop on one foot is normal, as this is a 4-year milestone.
To determine if a physical therapy referral is warranted.
2
Evaluate the patient's fine motor skills against standard milestones.
The patient copies a circle, which is a 3-year milestone. Her inability to copy a cross or square is normal, as these are 4-year milestones.
To determine if an occupational therapy referral is warranted.
3
Evaluate the patient's language and social skills against standard milestones.
The patient uses 3-word sentences, is 75% intelligible to strangers, and knows her name and age. These are all 3-year milestones.
To determine if speech or audiometry evaluations are warranted.
4
Synthesize the findings to formulate a management plan.
All observed milestones align perfectly with the child's chronological age of 36 months (3 years). No delays are present.
To select the appropriate clinical intervention.

Key Concept

Normal pediatric developmental milestones (3 years)
Question 1705Question →

A 12-month-old boy is brought to the pediatrician for a routine well-child visit. His medical history is significant for perinatal HIV infection. He is currently prescribed antiretroviral therapy, but his mother admits to frequently missing doses over the past few months. Recent laboratory studies show a CD4 T-lymphocyte count of 450 cells/mm³ and a CD4 percentage of 12%. The parents express concern about his physical development, noting that he is not yet able to run or kick a ball. On examination, the boy is alert and interactive. He can stand independently for a few seconds and uses a fine pincer grasp to pick up a raisin. He says "mama" and "dada" specifically and waves "bye-bye" to the clinician. He has received all previously recommended immunizations. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer age-appropriate inactivated vaccines only and reassure the parents regarding his development

Answer

The most appropriate next step is to administer age-appropriate inactivated vaccines only and reassure the parents regarding his development.
The correct action is to provide inactivated vaccines only and offer reassurance regarding development. Routine 12-month immunizations typically include inactivated vaccines (such as PCV, Hib, HepA) and live-attenuated vaccines (MMR, Varicella). However, for pediatric patients with perinatal HIV, the administration of live vaccines depends on their immune status. A CD4 percentage < 15% indicates severe immunosuppression, making live vaccines strictly contraindicated. Inactivated vaccines are safe and must be administered to protect this vulnerable patient. Regarding his development, standing alone, having a fine pincer grasp, saying specific words ("mama/dada"), and waving bye-bye are normal 12-month milestones. Running and kicking a ball are not expected until 18 to 24 months. Therefore, the parents should be reassured without needing a developmental referral.

Step-by-Step Solution

1
Evaluate the patient's immune status and determine vaccine eligibility.
The patient has HIV with a CD4 percentage of 12%, which defines severe immunosuppression in a child under 5 years old.
Live-attenuated vaccines (e.g., MMR, Varicella) are contraindicated in severely immunocompromised patients (CD4 < 15%) due to the risk of life-threatening vaccine-strain infection.
2
Identify the appropriate vaccines to administer at this 12-month visit.
The patient should receive scheduled inactivated vaccines (e.g., PCV, Hib, HepA) but not the normally scheduled 12-month live vaccines (MMR, Varicella).
Inactivated vaccines pose no risk of disseminated infection and should be given on schedule to protect the vulnerable host.
3
Assess the patient's developmental milestones against parental expectations.
The patient can stand independently, use a fine pincer grasp, say specific words, and wave bye-bye. These are appropriate 12-month milestones.
The parents expect 18- to 24-month milestones (running, kicking a ball). Reassurance is needed, not a developmental referral, as the child is developing normally for his age.

Key Concept

In pediatric patients with HIV, live-attenuated vaccines are contraindicated if there is severe immunosuppression (CD4 percentage < 15%). Normal 12-month milestones include standing independently, a fine pincer grasp, and saying 1-3 specific words.
Question 1706Question →

An internal medicine team is evaluating a 6767-year-old male who presented to the emergency department with a 55-day history of progressively worsening shortness of breath, orthopnea, and lower extremity swelling. His medical history includes seropositive rheumatoid arthritis, for which infliximab was added to his methotrexate regimen 44 months ago due to refractory joint pain. He also has a 3535-pack-year smoking history. On physical examination, his temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 112/74 mm Hg112/74\text{ mm Hg}, heart rate is 110 /min110\text{ /min}, and respiratory rate is 24 /min24\text{ /min}. Pulse oximetry shows 91%91\% on ambient air. Jugular venous distention is prominent at 4545 degrees. Chest auscultation reveals bilateral basilar crackles and a prominent third heart sound (S3). There is 2+2+ bilateral pitting edema extending to the knees. Joint examination shows no active synovitis, warmth, or effusions. Which of the following is the most appropriate next step in the pharmacologic management of this patient's current condition?

Show answer & explanation

Answer: Discontinue infliximab and administer intravenous furosemide

Answer

Discontinue infliximab and administer intravenous furosemide
The correct action is to discontinue the tumor necrosis factor-alpha (TNF-alpha) inhibitor and administer a loop diuretic. This patient presents with classic signs of acute decompensated heart failure, including orthopnea, jugular venous distention, an S3 gallop, pulmonary crackles, and peripheral edema. TNF-alpha inhibitors (e.g., infliximab, etanercept, adalimumab) are known to precipitate new-onset heart failure or exacerbate underlying cardiac dysfunction. They are strictly contraindicated in patients with moderate to severe heart failure. Therefore, the essential next step is to immediately stop the offending medication and administer intravenous furosemide to manage the severe volume overload.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the physical examination findings.
The patient exhibits jugular venous distention, an S3 gallop, bilateral basilar crackles, and pitting edema, which establish a diagnosis of acute decompensated heart failure (ADHF).
Differentiating between cardiac, pulmonary, and infectious causes of acute dyspnea is the critical first step in determining management.
2
Determine the most likely precipitating cause of the heart failure in this specific patient.
The recent initiation of infliximab is the most likely trigger, as tumor necrosis factor-alpha (TNF-alpha) inhibitors are a known cause of new-onset or worsening heart failure.
Identifying medication-induced complications is essential in patients on complex immunosuppressive regimens to prevent ongoing toxicity.
3
Select the appropriate pharmacologic management based on the diagnosis and precipitant.
Discontinuation of the offending agent (infliximab) and initiation of a loop diuretic (intravenous furosemide) for symptomatic relief of volume overload.
ADHF requires immediate volume offloading, and the precipitating cardiotoxic medication must be stopped immediately.

Key Concept

Tumor necrosis factor-alpha (TNF-alpha) inhibitors can precipitate or exacerbate heart failure and should be discontinued if a patient develops signs of acute decompensated heart failure.
Question 1707Question →

A 32-year-old man is admitted to the hospital with a 1-week history of fever, chills, and profound fatigue. He has a history of intravenous drug use and was treated for a skin abscess two months ago. His temperature is 38.8°C (101.8°F), blood pressure is 110/70 mm Hg, and pulse is 108/min. Physical examination reveals a new grade 3/6 holosystolic murmur best heard at the cardiac apex. Transesophageal echocardiography demonstrates a 1.2-cm mobile vegetation on the mitral valve. Three sets of blood cultures obtained on admission grow *Enterococcus faecalis* that is susceptible to ampicillin, vancomycin, gentamicin, and linezolid. The patient is initiated on continuous intravenous ampicillin and every-8-hour intravenous gentamicin. Over the next 48 hours, his clinical symptoms improve and his temperature decreases to 37.9°C (100.2°F). However, laboratory studies show his serum creatinine has increased from 0.8 mg/dL on admission to 2.5 mg/dL, and his urine output has been 350 mL over the past 24 hours. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Discontinue gentamicin and add intravenous ceftriaxone

Answer

Discontinue gentamicin and add intravenous ceftriaxone
The most appropriate modification to this patient's regimen is to discontinue gentamicin and add intravenous ceftriaxone. This patient has *Enterococcus faecalis* infective endocarditis and has developed severe acute kidney injury (AKI) secondary to gentamicin toxicity. Enterococci are intrinsically tolerant to the bactericidal effects of cell-wall active agents (like penicillins) when used alone. To achieve the bactericidal activity required to cure endocarditis, synergistic combination therapy is necessary. The standard first-line regimens are ampicillin plus an aminoglycoside (e.g., gentamicin) or ampicillin plus ceftriaxone. Although ceftriaxone has no clinically significant activity against enterococci on its own, it saturates specific penicillin-binding proteins (PBPs, primarily PBP 2 and 3), which works synergistically with ampicillin (which binds PBP 4) to provide bactericidal activity. Because the ampicillin plus ceftriaxone regimen is equally effective as ampicillin plus gentamicin but entirely avoids aminoglycoside-associated nephrotoxicity, it is the treatment of choice for *E. faecalis* endocarditis in patients who develop AKI during therapy or those with preexisting renal dysfunction.

Step-by-Step Solution

1
Identify the patient's primary diagnosis and current clinical status.
The patient has Enterococcus faecalis infective endocarditis and has developed oliguric acute kidney injury (AKI) while receiving ampicillin and gentamicin.
Establishing the current complication is necessary to determine the appropriate next step in management.
2
Evaluate the current antimicrobial regimen's role in the patient's complication.
Gentamicin is a well-known nephrotoxic agent and is the most likely cause of the acute kidney injury.
Identifying the offending agent allows for targeted modification of the regimen.
3
Determine the optimal alternative therapy that maintains efficacy while avoiding further toxicity.
Substituting ceftriaxone for gentamicin provides the necessary bactericidal synergy against E. faecalis without causing further nephrotoxicity.
Endocarditis requires bactericidal therapy, and the ampicillin-ceftriaxone combination achieves this synergy through complementary binding of penicillin-binding proteins.

Key Concept

Management of Enterococcus faecalis infective endocarditis in the setting of aminoglycoside-induced acute kidney injury.
Question 1708Question →

During routine well-child care, clinicians follow standardized periodicity schedules to ensure appropriate preventive screening for asymptomatic children and adolescents. Arrange the following universal preventive screening assessments in chronological order, starting with the earliest recommended age of initial administration to the latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the initial administration of these universal screenings is: Autism spectrum disorder (18 months), Dyslipidemia (9-11 years), Major depressive disorder (12 years), and HIV infection (15-18 years).
Preventive care guidelines emphasize specific universal screening milestones. Autism screening is performed in early toddlerhood (18 and 24 months). Dyslipidemia screening is universally performed in late childhood (9-11 years) before pubertal lipid shifts. Depression screening is initiated in early adolescence (12 years) and performed annually thereafter. Finally, a one-time universal HIV screen is recommended in mid-to-late adolescence (15-18 years).

Step-by-Step Solution

1
Determine the initial age for universal autism spectrum disorder (ASD) screening.
ASD screening is universally conducted at 18 and 24 months.
Early identification and intervention for neurodevelopmental delays significantly improve long-term outcomes.
2
Determine the initial age for universal dyslipidemia screening.
Lipid screening is universally conducted once between 9 and 11 years of age.
Targeted screening misses a significant portion of children with familial hypercholesterolemia. Screening is done before puberty because normal pubertal changes can falsely lower HDL and raise triglycerides.
3
Determine the initial age for universal depression screening.
Depression screening begins at age 12 years.
The incidence of major depressive disorder rises sharply during adolescence, making annual screening critical starting at this age.
4
Determine the age for universal HIV screening.
HIV screening is conducted at least once between 15 and 18 years of age.
This captures the population as they enter peak years of sexual debut, recognizing that relying solely on risk-based screening misses many infected youth.

Key Concept

Chronological timeline of routine universal pediatric and adolescent preventive screenings
Question 1709Question →

A 22-year-old man presents to the emergency department with a 2-day history of worsening nausea, diffuse abdominal pain, and profound fatigue. He has been excessively thirsty and urinating frequently. He has no significant past medical history. His temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 98/60 mmHg98/60\text{ mmHg}, heart rate is 118/min118/\text{min}, and respiratory rate is 24/min24/\text{min} with deep, rapid breaths. Mucous membranes are dry. The abdomen is diffusely tender but soft without rebound. Point-of-care testing reveals a capillary blood glucose of 480 mg/dL480\text{ mg/dL} and large blood ketones. An arterial blood gas shows a pH of 7.187.18. The patient is diagnosed with an acute endocrine emergency.

Arrange the following management steps in the most appropriate algorithmic sequence for the acute stabilization and definitive therapy of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing Diabetic Ketoacidosis is: 1) Administer intravenous isotonic crystalloid, 2) Assess serum potassium, 3) Initiate intravenous regular insulin, 4) Add dextrose to intravenous fluids when glucose falls to 200-250 mg/dL200\text{-}250\text{ mg/dL}, and 5) Transition to subcutaneous insulin once the anion gap is closed.
The exact algorithmic sequence for DKA ensures physiological safety. Fluid resuscitation immediately addresses life-threatening hypovolemia. Assessing potassium ensures insulin can be given safely without precipitating lethal arrhythmias. Insulin stops the underlying pathophysiology (ketogenesis). Adding dextrose prevents iatrogenic hypoglycemia while the insulin finishes clearing the acid load. Finally, transitioning to subcutaneous insulin represents the resolution of the acute crisis and return to maintenance therapy.

Step-by-Step Solution

1
Synthesize the clinical diagnosis based on the vignette.
The patient is experiencing Diabetic Ketoacidosis (DKA).
The clinical presentation of polyuria, polydipsia, abdominal pain, Kussmaul respirations, profound hyperglycemia (480 mg/dL480\text{ mg/dL}), ketonemia, and severe metabolic acidosis (pH 7.187.18) is diagnostic of DKA.
2
Determine the highest priority in acute stabilization.
Aggressive fluid resuscitation with 0.9%0.9\% normal saline.
Patients with DKA have profound osmotic diuresis leading to severe total body water deficits (often 5-8 L5\text{-}8\text{ L}). Restoring intravascular volume is the absolute first step to prevent cardiovascular collapse and acute renal failure.
3
Identify the prerequisite safety check before starting specific medical therapy.
Check the serum potassium level.
Patients with DKA often have total body potassium depletion despite normal or high serum levels. Insulin drives potassium intracellularly. If baseline potassium is <3.3 mEq/L<3.3\text{ mEq/L}, insulin must be withheld until potassium is replaced to avoid lethal arrhythmias.
4
Establish the sequence of medication administration and subsequent fluid adjustment.
Start an intravenous regular insulin infusion, then add 5%5\% dextrose when glucose reaches 200 mg/dL200\text{ mg/dL}.
Insulin is required to suppress lipolysis and resolve the ketoacidosis. Once glucose levels drop significantly, dextrose is added to prevent hypoglycemia while allowing the continuous insulin infusion to finish closing the anion gap.
5
Determine the criteria for transitioning to maintenance therapy.
Switch to subcutaneous insulin.
Once the anion gap closes, acidosis resolves, and the patient can eat, an overlapping transition to subcutaneous basal-bolus insulin is performed.

Key Concept

The algorithmic management of Diabetic Ketoacidosis requires strict sequential therapy: aggressive fluid resuscitation, potassium assessment prior to insulin initiation, fluid modification with dextrose, and eventual transition to subcutaneous insulin once the anion gap closes.
Question 1710Question →

During morning rounds, a 5858-year-old male inpatient is evaluated on postoperative day 77 following an open partial gastrectomy for gastric adenocarcinoma. The patient reports new-onset severe right calf pain and swelling that began earlier this morning, along with mild shortness of breath. His medications include pantoprazole and subcutaneous unfractionated heparin, which was started postoperatively for venous thromboembolism prophylaxis. Temperature is 37.8∘C37.8^\circ \text{C} (100.0∘F100.0^\circ \text{F}), blood pressure is 135/85 mmHg135/85 \text{ mmHg}, pulse is 105/min105/\text{min}, and respirations are 18/min18/\text{min}. Pulse oximetry shows 96%96\% on room air. Physical examination reveals a swollen, erythematous, and tender right calf. Lungs are clear to auscultation bilaterally.

Complete laboratory panel shows:
Laboratory TestResult
Hemoglobin11.2 g/dL11.2 \text{ g/dL}
Leukocyte count8,500/μL8,500/\mu\text{L}
Platelet count105,000/μL105,000/\mu\text{L} (Baseline prior to surgery: 240,000/μL240,000/\mu\text{L})
Serum creatinine1.1 mg/dL1.1 \text{ mg/dL}
Prothrombin time12 seconds12 \text{ seconds}
Activated partial thromboplastin time32 seconds32 \text{ seconds}

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue unfractionated heparin and initiate argatroban

Answer

The correct answer is to discontinue unfractionated heparin and initiate a non-heparin anticoagulant such as argatroban.
This patient's clinical presentation is highly suspicious for type 2 Heparin-Induced Thrombocytopenia (HIT) complicated by a new deep vein thrombosis (DVT). The diagnosis of HIT is assessed using the '4 T's' score, which evaluates Timing (typically 55-1010 days after heparin exposure), Thrombocytopenia (a greater than 50%50\% drop from baseline), Thrombosis (new venous or arterial clots), and the absence of oTher causes. This patient meets the criteria for a high-probability score (day 77, >50%>50\% platelet drop, and a new DVT). The immediate, life-saving next step in management is to strictly discontinue all heparin exposure (including line flushes) and immediately initiate therapeutic anticoagulation with a non-heparin agent, such as a direct thrombin inhibitor (e.g., argatroban) or fondaparinux, to prevent further massive thrombosis.

Step-by-Step Solution

1
Calculate the patient's '4 T's' score for Heparin-Induced Thrombocytopenia (HIT).
The patient has appropriate Timing (day 7 of therapy), significant Thrombocytopenia (drop from 240,000 to 105,000, which is >50%), and a new Thrombosis (clinical symptoms of DVT), making HIT highly probable.
Recognizing the clinical triad of heparin exposure, platelet drop, and new thrombosis is required to correctly diagnose HIT.
2
Determine the immediate management for high-probability HIT.
All heparin products must be stopped immediately. Waiting for confirmatory laboratory testing (e.g., serotonin release assay) is inappropriate.
Continued exposure to heparin will worsen the hypercoagulable state and lead to severe complications like pulmonary embolism or limb ischemia.
3
Select the appropriate alternative therapy.
Therapeutic anticoagulation with a non-heparin agent (e.g., direct thrombin inhibitors like argatroban or bivalirudin, or fondaparinux) must be initiated.
Anticoagulation is required because HIT is a highly prothrombotic state. Low-molecular-weight heparins (like enoxaparin) cannot be used due to cross-reactivity.

Key Concept

Diagnosis and acute management of Heparin-Induced Thrombocytopenia (HIT)
Question 1711Question →

A male patient, aged 4848, presents to an ambulatory care facility reporting a 66-week history of a persistent cough and episodes of blood-tinged sputum. Over this same period, he has experienced recurrent nosebleeds, intermittent low-grade fevers, and profound fatigue. His medical history includes major depressive disorder, for which he has been taking citalopram for the last 33 years. He does not smoke or use illicit drugs.

Vital signs show a temperature of 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}), blood pressure of 152/96 mm Hg152/96\text{ mm Hg}, heart rate of 88/min88/\text{min}, and respiratory rate of 16/min16/\text{min}.

Examination of the nasal cavity reveals mucosal ulcerations and adherent crusts. Auscultation of the lungs demonstrates scattered crackles in the right middle lung field.

Laboratory studies reveal:
Hemoglobin: 10.2 g/dL10.2\text{ g/dL}
Leukocyte count: 11,500/mm311,500/\text{mm}^3
Blood urea nitrogen: 34 mg/dL34\text{ mg/dL}
Serum creatinine: 2.2 mg/dL2.2\text{ mg/dL} (was 0.8 mg/dL0.8\text{ mg/dL} during a routine checkup 88 months ago)
Urinalysis: 2+2+ protein, large blood, >50 red blood cells/hpf>50\text{ red blood cells/hpf}, and several red blood cell casts.

A radiograph of the chest demonstrates a 3.5-cm3.5\text{-cm} cavitary lesion in the right middle lobe with thick walls.

Based on the most likely diagnosis, which of the following is the most appropriate next step in evaluation or management?

Show answer & explanation

Answer: Measurement of serum autoantibodies against proteinase-3 and myeloperoxidase

Answer

Measurement of serum autoantibodies against proteinase-3 and myeloperoxidase
The correct answer is the measurement of serum autoantibodies against proteinase-3 and myeloperoxidase. This patient presents with the classic triad of Granulomatosis with Polyangiitis (GPA): upper respiratory tract disease (recurrent epistaxis, nasal ulcerations/crusting), lower respiratory tract disease (cough, hemoptysis, cavitary lung lesion), and glomerulonephritis (hypertension, elevated creatinine, hematuria, and red blood cell casts). GPA is an ANCA-associated small-vessel vasculitis. The most appropriate initial non-invasive step in the diagnostic workup is testing for anti-neutrophil cytoplasmic antibodies (ANCA). Approximately 90% of patients with active systemic GPA will test positive for c-ANCA (which targets proteinase-3, or PR3). Once seropositivity is confirmed, a tissue biopsy (typically from the kidney or upper airway) is obtained for definitive diagnosis.

Step-by-Step Solution

1
Analyze the clinical triad of symptoms
The patient exhibits upper respiratory tract involvement (epistaxis, nasal mucosal ulcerations), lower respiratory tract involvement (hemoptysis, cavitary lung lesion), and renal involvement (acute kidney injury with red blood cell casts indicating glomerulonephritis).
Identifying the pattern of organ involvement is crucial for recognizing specific systemic vasculitides.
2
Formulate the most likely diagnosis
The combination of this triad is highly characteristic of Granulomatosis with Polyangiitis (GPA, formerly Wegener's granulomatosis).
GPA uniquely causes necrotizing granulomatous inflammation affecting these three distinct vascular beds.
3
Determine the best initial diagnostic step
Serologic testing for anti-neutrophil cytoplasmic antibodies (ANCA), specifically PR3-ANCA and MPO-ANCA.
While a tissue biopsy (often nasal or renal) is required for definitive confirmation, ANCA testing is the most appropriate, rapid, and non-invasive initial step to support the diagnosis and guide urgent immunosuppressive therapy.

Key Concept

The classic presentation and initial diagnosis of Granulomatosis with Polyangiitis (GPA)
Estimated Time:1m 15s
Question 1712Question →

A 32-year-old woman with a history of systemic lupus erythematosus and recurrent kidney stones is evaluated in the clinic for progressive, generalized muscle weakness over the past two weeks. She reports difficulty climbing stairs and rising from a seated position. She denies diarrhea, vomiting, fever, or recent illnesses. Her vital signs are within normal limits. Physical examination reveals symmetric proximal muscle weakness in the bilateral lower extremities with diminished deep tendon reflexes.

Laboratory evaluation shows the following:

Serum chemistry:
Sodium: 140 mEq/L
Potassium: 2.6 mEq/L
Chloride: 114 mEq/L
Bicarbonate: 14 mEq/L
Blood urea nitrogen: 16 mg/dL
Creatinine: 0.9 mg/dL

Arterial blood gas (room air):
pH: 7.26
pCO2: 29 mm Hg
pO2: 96 mm Hg

Urinalysis reveals a pH of 6.8 with no protein or blood.

Based on the provided laboratory data, which of the following statements is most accurate regarding this patient's current acid-base physiological state?

Show answer & explanation

Answer: The respiratory system has appropriately responded to a primary loss of serum buffering capacity.

Answer

The respiratory system has appropriately responded to a primary loss of serum buffering capacity.
The patient's laboratory results demonstrate an acidemic pH driven by low bicarbonate, confirming a primary metabolic acidosis (loss of serum buffers). The anion gap is normal (1212 mEq/L). To assess respiratory compensation, Winter's formula is applied: Expected pCO2=1.5×14+8=29\text{Expected pCO}_2 = 1.5 \times 14 + 8 = 29 (range 27−3127-31 mm Hg). Because the patient's actual pCO2 is 2929 mm Hg, the respiratory system has mounted a completely appropriate physiological response.

Step-by-Step Solution

1
Evaluate the arterial pH to determine the primary direction of the disturbance.
The pH is 7.26, which is strictly acidemic (normal 7.35 - 7.45).
Establishing acidemia helps differentiate whether subsequent abnormalities are primary drivers or compensatory mechanisms.
2
Examine the serum bicarbonate and pCO2 to identify the primary etiology.
The serum bicarbonate is significantly low at 14 mEq/L, which aligns with the acidemic pH. This indicates a primary metabolic acidosis (loss of serum buffering capacity).
The primary disorder must match the direction of the pH shift.
3
Calculate the serum anion gap to characterize the metabolic acidosis.
Anion Gap=Na+−(Cl−+HCO3−)=140−(114+14)=12\text{Anion Gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 140 - (114 + 14) = 12 mEq/L. This is a normal anion gap.
Differentiating between normal and high anion gap metabolic acidosis is crucial for diagnosing the underlying disease (e.g., Renal Tubular Acidosis vs. Lactic Acidosis).
4
Apply Winter's formula to determine if the respiratory compensation is appropriate.
Expected pCO2=(1.5×HCO3−)+8±2=(1.5×14)+8±2=29±2\text{Expected pCO}_2 = (1.5 \times \text{HCO}_3^-) + 8 \pm 2 = (1.5 \times 14) + 8 \pm 2 = 29 \pm 2 mm Hg. The actual pCO2 is exactly 29 mm Hg.
If the measured pCO2 falls within the calculated expected range, the patient has an appropriately compensated simple metabolic acidosis without any superimposed respiratory disorders.

Key Concept

The physiological diagnosis of a simple, compensated normal anion gap metabolic acidosis requires calculating the anion gap and confirming the adequacy of respiratory compensation using Winter's formula.
Question 1713Question →

Match each clinical vignette describing a systemic fungal infection with the most appropriate first-line pharmacotherapy.

Click a left item, then click its matching right item

Items

A 45-year-old immunocompetent man from Wisconsin with a 6-week history of productive cough, low-grade fever, and a verrucous, crusted plaque on his forearm. Sputum cytology reveals large, broad-based budding yeasts. He is hemodynamically stable with no neurologic symptoms.
A 32-year-old man with advanced HIV presents with a 4-week history of fever, significant weight loss, hepatosplenomegaly, and painful palatal ulcers. Bone marrow biopsy demonstrates small oval yeasts packed closely within macrophages.
A 38-year-old woman with advanced HIV presents with a 2-week history of worsening headache, nausea, and lethargy. Lumbar puncture reveals an opening pressure of 320 mm H2O. CSF India ink preparation reveals heavily encapsulated budding yeasts.
A 55-year-old man with acute myeloid leukemia and profound neutropenia for 15 days develops fever, pleuritic chest pain, and hemoptysis. Chest computed tomography shows a right upper lobe macronodule surrounded by a ground-glass opacity (halo sign).

Matches

Show answer & explanation

Answer

Mild-to-moderate blastomycosis is matched with oral itraconazole; Disseminated histoplasmosis is matched with intravenous liposomal amphotericin B followed by oral itraconazole; Cryptococcal meningoencephalitis is matched with intravenous liposomal amphotericin B plus oral flucytosine; Invasive pulmonary aspergillosis is matched with intravenous voriconazole.
Each fungal infection dictates a highly specific regimen. Mild blastomycosis is successfully treated with itraconazole. Disseminated histoplasmosis demands amphotericin B induction followed by itraconazole maintenance. Cryptococcal meningitis requires synergistic amphotericin B and flucytosine to clear the CNS. Invasive aspergillosis uniquely requires the mold-active triazole voriconazole.

Step-by-Step Solution

1
Analyze the first vignette to determine the pathogen and disease severity.
Broad-based budding yeasts in a stable patient from Wisconsin indicates mild-to-moderate blastomycosis, which responds well to oral triazoles.
Accurate pathogen identification and severity stratification dictate whether oral or intravenous antifungal therapy is required.
2
Analyze the second vignette for pathogen morphology and clinical status.
Intracellular yeasts in macrophages with hepatosplenomegaly in an HIV patient indicates progressive disseminated histoplasmosis, requiring aggressive two-step therapy.
Disseminated endemic mycoses in severely immunocompromised hosts are fatal without rapid, broad fungicidal induction.
3
Evaluate the third vignette based on CSF findings.
Encapsulated yeasts in CSF with high opening pressure indicates cryptococcal meningitis, necessitating combination therapy that penetrates the blood-brain barrier.
CNS fungal infections require specific regimens optimized for rapid CSF sterilization to prevent mortality.
4
Interpret the fourth vignette's radiologic and hematologic clues.
A prolonged neutropenic patient with hemoptysis and a CT halo sign has invasive pulmonary aspergillosis, requiring targeted mold-active therapy.
Aspergillus is an angioinvasive mold; its treatment fundamentally differs from yeast infections.

Key Concept

Definitive Pharmacotherapy for Systemic Fungal Infections based on Pathogen and Disease Severity
Question 1714Question →

Emergency medical services transport a 6565-year-old man from a long-term care facility to the hospital due to acute-onset confusion, fever, and severe abdominal pain. His past medical history is significant for alcohol-associated cirrhosis with refractory ascites, which is managed with high-dose furosemide and spironolactone. Upon arrival, his temperature is 39.2∘39.2^\circ C (102.6∘102.6^\circ F), blood pressure is 80/5080/50 mm Hg, heart rate is 122122/min, and respiratory rate is 2828/min. Abdominal examination reveals severe distension, diffuse tenderness, and involuntary guarding. Laboratory results are as follows:

Laboratory TestResult
Sodium132132 mEq/L
Potassium3.13.1 mEq/L
Chloride8282 mEq/L
Bicarbonate1616 mEq/L
Blood urea nitrogen4545 mg/dL
Creatinine2.22.2 mg/dL
Lactate7.57.5 mmol/L
Arterial blood gas (room air):
ParameterResult
pH7.507.50
pCO2_22121 mm Hg
pO2_26868 mm Hg

Based on the clinical presentation and laboratory results, which of the following sets of acid-base disorders is present in this patient?

Show answer & explanation

Answer: High anion gap metabolic acidosis, metabolic alkalosis, and respiratory alkalosis

Answer

The correct answer is the set containing a high anion gap metabolic acidosis, a metabolic alkalosis, and a respiratory alkalosis.
The patient's ABG shows an alkalemia (pH > 7.457.45) driven by hypocapnia (pCO 2_2 < 4040 mm Hg), indicating a primary respiratory alkalosis. This is clinically consistent with hyperventilation due to severe sepsis and fever. Next, calculating the anion gap (AG): AG = Na +^+ - (Cl −^- + HCO 3−_3^-) = 132−(82+16)=34132 - (82 + 16) = 34 mEq/L. Since the normal AG is 1212 mEq/L, an AG of 3434 confirms the presence of a high anion gap metabolic acidosis (HAGMA), resulting from lactic acidosis due to septic shock. Finally, to check for a third disorder, a delta-delta calculation is performed. The Δ\Delta AG is 34−12=2234 - 12 = 22. The corrected HCO 3−_3^- = measured HCO 3−_3^- + Δ\Delta AG = 16+22=3816 + 22 = 38 mEq/L. Because the corrected HCO 3−_3^- (3838 mEq/L) is significantly greater than the normal baseline (2424 mEq/L), there is a concurrent metabolic alkalosis. This is clinically explained by the patient's ongoing use of high-dose loop diuretics for his cirrhosis. Therefore, a triple acid-base disorder is present.

Step-by-Step Solution

1
Analyze the pH to determine the primary acid-base disturbance.
The pH is 7.507.50, indicating alkalemia.
Establishing the primary disturbance helps anchor the subsequent interpretation.
2
Evaluate the pCO 2_2 and HCO 3−_3^- to identify the driver of the alkalemia.
The pCO 2_2 is markedly low at 2121 mm Hg, and the HCO 3−_3^- is low at 1616 mEq/L. The low pCO 2_2 explains the alkalemia, confirming a primary respiratory alkalosis.
Respiratory alkalosis in this patient is driven by hyperventilation secondary to sepsis and fever.
3
Calculate the anion gap (AG) to check for a metabolic acidosis.
AG = Na +^+ - (Cl −^- + HCO 3−_3^-) = 132−(82+16)=34132 - (82 + 16) = 34 mEq/L.
An AG > 1212 mEq/L indicates a high anion gap metabolic acidosis (HAGMA), driven here by lactic acidosis from septic shock.
4
Perform a delta-delta calculation to unmask any hidden third disorder.
Δ\Delta AG = 34−12=2234 - 12 = 22. Corrected HCO 3−_3^- = measured HCO 3−_3^- (1616) + Δ\Delta AG (2222) = 3838 mEq/L.
Because the corrected HCO 3−_3^- (3838 mEq/L) is significantly greater than the baseline of 2424 mEq/L, there is a concurrent metabolic alkalosis, likely secondary to loop diuretic therapy.

Key Concept

Diagnosis of triple acid-base disorders using the anion gap and delta-delta calculations.

Alternative Method

Instead of using the corrected bicarbonate formula, the delta ratio (Δ\Delta AG / Δ\Delta HCO 3−_3^-) can be used. Δ\Delta AG = 34−12=2234 - 12 = 22. Δ\Delta HCO 3−_3^- = 24−16=824 - 16 = 8. The delta ratio is 22/8=2.7522 / 8 = 2.75. A delta ratio greater than 2.02.0 confirms the presence of a concurrent metabolic alkalosis.
Estimated Time:2m 0s
Question 1715Question →

Match each classic pediatric respiratory clinical presentation with its most likely causative pathogen.

Click a left item, then click its matching right item

Items

Barking, seal-like cough, hoarseness, and inspiratory stridor that worsens at night
Copious clear rhinorrhea, tachypnea, retractions, and diffuse wheezing in a 4-month-old infant
Abrupt onset of high fever, severe sore throat, drooling, and leaning forward in a tripod position
Two weeks of mild coryza followed by severe, prolonged coughing spells ending with a loud inspiratory whoop and emesis

Matches

Show answer & explanation

Answer

The barking cough matches Parainfluenza virus; the infant wheezing matches Respiratory syncytial virus; the drooling/tripod position matches Haemophilus influenzae type b; and the paroxysmal cough with whoop matches Bordetella pertussis.
Each clinical presentation describes a hallmark pediatric respiratory syndrome that has a well-established primary pathogen. Recognizing these buzzword presentations (barking cough, diffuse infant wheezing, tripod positioning, inspiratory whoop) is essential for rapid diagnosis and appropriate management.

Step-by-Step Solution

1
Analyze each clinical presentation to identify the specific pediatric respiratory syndrome.
The identified syndromes are: Croup (left_1), Bronchiolitis (left_2), Epiglottitis (left_3), and Pertussis (left_4).
Recognizing the clinical syndrome from classic symptoms is the necessary first step before etiology can be determined.
2
Match each identified syndrome with its most common causative pathogen.
Croup is paired with Parainfluenza, Bronchiolitis with RSV, Epiglottitis with Hib, and Pertussis with Bordetella.
These represent the classic, high-yield epidemiological associations for pediatric respiratory infections.

Key Concept

Classic pediatric respiratory syndromes and their primary causative pathogens
Estimated Time:1m 0s
Question 1716Question →

During routine evaluations in the newborn nursery and outpatient pediatric clinic, various abdominal and genitourinary structural anomalies are identified. Accurate diagnosis relies on distinct physical characteristics, which directly dictate the need for further workup and specific prognostic counseling. Match each neonatal clinical presentation to its corresponding underlying pathophysiologic mechanism and classic clinical associations.

Click a left item, then click its matching right item

Items

A newborn is noted to have a midline abdominal defect covered by a transparent, avascular membranous sac containing the liver and small bowel.
A premature neonate presents with edematous, thickened intestinal loops protruding through a right-sided paraumbilical defect without any covering membrane.
A 1-month-old infant exhibits a soft, compressible, skin-covered protrusion at the umbilicus that enlarges significantly during crying episodes.
A 2-week-old male infant presents with a painless, transilluminating scrotal swelling that becomes more prominent throughout the course of the day.

Matches

Show answer & explanation

Answer

The midline membrane-covered defect matches with failure of the midgut to return to the cavity (Omphalocele). The eviscerated bowel lacking a membrane matches with vascular compromise and bowel atresia risk (Gastroschisis). The skin-covered umbilical bulge matches with incomplete fascial closure and hypothyroidism risk (Umbilical hernia). The fluctuant scrotal swelling matches with incomplete obliteration of the processus vaginalis (Communicating hydrocele).
Each neonatal presentation correlates precisely with a specific embryologic defect and clinical association. Omphalocele features a membranous sac, is midline, and carries a high risk of chromosomal aneuploidies. Gastroschisis is a paraumbilical defect lacking a sac, typically caused by a vascular accident, predisposing the infant to intestinal atresia. Umbilical hernias are skin-covered fascial defects associated with congenital hypothyroidism. Communicating hydroceles involve a patent processus vaginalis that fluctuates with peritoneal fluid and predisposes to indirect inguinal hernias.

Step-by-Step Solution

1
Evaluate the presentation of a midline abdominal defect covered by a membranous sac.
Identified as an omphalocele, which matches the mechanism involving failure of the midgut to return to the abdominal cavity and carries a high risk for chromosomal abnormalities.
Differentiating omphalocele from gastroschisis is critical for genetic counseling; omphalocele requires screening for trisomies and Beckwith-Wiedemann syndrome.
2
Analyze the right-sided paraumbilical defect with exposed, edematous bowel.
Identified as gastroschisis, which aligns with the mechanism of early vascular compromise and carries a risk of intestinal atresia.
Gastroschisis lacks a membranous sac, exposing the bowel to amniotic fluid which causes inflammation and dysmotility, but unlike omphalocele, it is not typically linked to aneuploidy.
3
Assess the presentation of a skin-covered bulge at the umbilicus in a 1-month-old.
Identified as an umbilical hernia, matching the mechanism of incomplete fascial ring closure.
Umbilical hernias are distinctively covered by skin. Recognizing this benign finding is important, but clinicians must also maintain a high index of suspicion for associated congenital hypothyroidism.
4
Examine the painless, transilluminating scrotal mass that fluctuates in size.
Identified as a communicating hydrocele, matching the mechanism of a patent processus vaginalis.
The fluctuating size indicates a connection to the peritoneal cavity. This same anatomic defect is the exact pathway through which indirect inguinal hernias develop.

Key Concept

Clinical differentiation and embryologic origins of neonatal abdominal wall defects and groin masses.
Estimated Time:1m 30s
Question 1717Question →

Match each characteristic physical examination or radiographic hand finding to the most likely underlying rheumatologic or musculoskeletal condition.

Click a left item, then click its matching right item

Items

Reducible ulnar deviation of the metacarpophalangeal joints and swan-neck deformities without radiographic evidence of periarticular bone erosions
Pencil-in-cup appearance on plain radiography accompanied by concurrent diffuse, painful swelling of an entire digit
Hook-like osteophytes at the second and third metacarpophalangeal joints, often accompanied by chondrocalcinosis
Asymmetric periarticular erosions with overhanging cortical edges, frequently described as 'rat-bite' lesions
Squaring of the first carpometacarpal joint with firm, bony enlargement of the distal interphalangeal joints

Matches

Show answer & explanation

Answer

The correct matches correlate specific patterns of joint involvement and radiographic destruction to their classic etiologies: SLE (Jaccoud arthropathy), Psoriatic arthritis (pencil-in-cup, dactylitis), Hemochromatosis (2nd/3rd MCP hook-like osteophytes), Gout (rat-bite erosions), and Osteoarthritis (1st CMC squaring, Heberden nodes).
Each condition presents with a highly specific anatomical and radiographic pattern. SLE features ligamentous laxity without bone erosion (Jaccoud arthropathy). Psoriatic arthritis combines inflammation of the entire digit (dactylitis) with aggressive osteolysis (pencil-in-cup). Hemochromatosis uniquely targets the 2nd and 3rd MCP joints. Chronic gout produces asymmetric, overhanging erosions from tophi. Osteoarthritis targets the DIP and 1st CMC joints with osteophyte formation rather than inflammatory erosions.

Step-by-Step Solution

1
Analyze the description of non-erosive, reducible hand deformities.
Matches with Systemic lupus erythematosus.
Reducible deformities without bone destruction are the hallmark of Jaccoud arthropathy, typical of SLE.
2
Identify the etiology of diffuse digit swelling with 'pencil-in-cup' destructive changes.
Matches with Psoriatic arthritis.
Dactylitis and aggressive focal osteolysis at the interphalangeal joints point directly to psoriatic arthritis.
3
Evaluate atypical metacarpophalangeal involvement featuring hook-like osteophytes.
Matches with Hemochromatosis-associated arthropathy.
The 2nd and 3rd MCP joints are classically affected in hemochromatosis, distinctly differentiating it from primary osteoarthritis.
4
Associate periarticular erosions featuring overhanging edges with a specific crystal arthropathy.
Matches with Chronic tophaceous gout.
Tophi cause mechanical displacement and erosions of adjacent bone, producing the classic 'rat-bite' radiographic appearance.
5
Recognize classic degenerative changes involving the thumb base and distal fingers.
Matches with Osteoarthritis.
Squaring of the 1st CMC joint and bony hypertrophy of the DIP joints (Heberden nodes) are the most common presentations of primary osteoarthritis.

Key Concept

Distinctive radiographic and clinical hand findings reliably differentiate among various crystal-induced, autoimmune, and degenerative arthropathies.
Estimated Time:2m 0s
Question 1718Question →

A 54-year-old man with a history of severe alcohol use disorder is admitted to the intensive care unit with acute necrotizing pancreatitis. Over the past 72 hours, he has experienced intractable vomiting and an inability to tolerate any oral intake. On physical examination, the patient is lethargic. Mucous membranes are extremely dry, and skin turgor is poor. Vital signs show a blood pressure of 88/50 mmHg, a pulse of 118/min, and a respiratory rate of 22/min.

Laboratory studies reveal the following:

VariableValue
Sodium (Na+Na^+)138 mEq/L
Potassium (K+K^+)3.1 mEq/L
Chloride (Cl−Cl^-)92 mEq/L
Bicarbonate (HCO3−HCO_3^-)16 mEq/L
Blood urea nitrogen (BUN)45 mg/dL
Creatinine2.1 mg/dL
Albumin1.6 g/dL
Lactic acid6.2 mmol/L

The physician evaluates the patient's acid-base status. Assuming a baseline normal anion gap of 12 mEq/L and a normal serum bicarbonate of 24 mEq/L, what is the patient's calculated delta ratio (ΔAG/ΔHCO3−\Delta\text{AG}/\Delta\text{HCO}_3^-) after appropriately correcting the anion gap for his hypoalbuminemia?

Show answer & explanation

Answer: 3

Answer

3.0
This patient has an elevated anion gap metabolic acidosis secondary to profound lactic acidosis (from tissue hypoperfusion) and likely starvation ketoacidosis. Concurrently, his intractable vomiting introduces a primary metabolic alkalosis. To accurately quantify this mixed disorder, the delta ratio must be calculated. First, the measured anion gap is calculated as 138−(92+16)=30138 - (92 + 16) = 30 mEq/L. Because albumin is a major circulating unmeasured anion, severe hypoalbuminemia (1.6 g/dL) falsely lowers the measured anion gap. The corrected anion gap is 30+2.5×(4.0−1.6)=3630 + 2.5 \times (4.0 - 1.6) = 36 mEq/L. The ΔAG\Delta\text{AG} is 36−12=2436 - 12 = 24 mEq/L. The change in bicarbonate (ΔHCO3−\Delta\text{HCO}_3^-) is 24−16=824 - 16 = 8 mEq/L. The delta ratio is 24/8=3.024 / 8 = 3.0. A delta ratio greater than 2.0 indicates that the bicarbonate is higher than expected, confirming a concurrent metabolic alkalosis (from vomiting).

Step-by-Step Solution

1
Calculate the measured anion gap (AG).
138 - (92 + 16) = 30 mEq/L.
The standard anion gap is necessary to identify the presence of unmeasured anions (e.g., lactate).
2
Correct the anion gap for hypoalbuminemia.
30 + 2.5 \times (4.0 - 1.6) = 30 + 2.5 \times 2.4 = 30 + 6.0 = 36 mEq/L.
Albumin is a major unmeasured weak acid. In severe hypoalbuminemia, the measured anion gap is falsely lowered and must be corrected to reveal the true extent of the metabolic acidosis.
3
Calculate the change in anion gap (ΔAG\Delta\text{AG}).
36 - 12 = 24 mEq/L.
This value represents the excess unmeasured anions above the baseline normal value of 12 mEq/L.
4
Calculate the change in bicarbonate (ΔHCO3−\Delta\text{HCO}_3^-).
24 - 16 = 8 mEq/L.
This determines how much the serum bicarbonate has fallen from the normal baseline of 24 mEq/L due to buffering.
5
Calculate the delta ratio.
24 / 8 = 3.0.
The delta ratio compares the rise in unmeasured anions to the fall in bicarbonate, helping to identify mixed acid-base disorders.

Key Concept

In patients with high anion gap metabolic acidosis, the measured anion gap must be corrected for hypoalbuminemia before calculating the delta ratio to accurately identify mixed acid-base disorders.
Question 1719Question →

A 4545-year-old woman is brought to the emergency department by her husband due to a severe, throbbing headache, blurred vision, and worsening shortness of breath over the past 4848 hours. She was diagnosed with diffuse cutaneous systemic sclerosis 33 years ago. Her home medications include mycophenolate mofetil. She recently visited an urgent care clinic for dysuria, and a urine culture sent at that time grew >100,000>100,000 CFU/mL of *Escherichia coli* susceptible to amoxicillin, nitrofurantoin, and ceftriaxone. She has not yet started antibiotic therapy.

Today, her temperature is 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F), blood pressure is 225/125225/125 mmHg, pulse is 110110/min, and respirations are 2626/min. Oxygen saturation is 93%93\% on room air. Physical examination reveals taut, thickened skin over the face, chest, and upper extremities. Funduscopic examination demonstrates bilateral papilledema and flame-shaped hemorrhages. Lung auscultation reveals fine bibasilar crackles.

Laboratory results are as follows:

TestResultReference Range
Hemoglobin8.98.9 g/dL12.0−16.012.0-16.0 g/dL
Platelets85,00085,000/mm³150,000−400,000150,000-400,000/mm³
Serum creatinine3.43.4 mg/dL (baseline 0.80.8)0.6−1.10.6-1.1 mg/dL
Thyroid-stimulating hormone (TSH)2.22.2 μ\muU/mL0.5−5.00.5-5.0 μ\muU/mL
Free T40.70.7 ng/dL0.9−1.70.9-1.7 ng/dL

Arterial blood gas on room air:
pH: 7.327.32
pCO₂: 3030 mmHg
pO₂: 7272 mmHg
HCO₃⁻: 1515 mEq/L

Peripheral blood smear shows numerous schistocytes.

Which of the following is the most appropriate initial step in the management of this patient's condition?

Show answer & explanation

Answer: Initiate therapy with an angiotensin-converting enzyme inhibitor

Answer

Initiate therapy with an angiotensin-converting enzyme inhibitor
The correct intervention is to initiate an angiotensin-converting enzyme (ACE) inhibitor. This patient is experiencing scleroderma renal crisis (SRC), a medical emergency classically seen in diffuse cutaneous systemic sclerosis. It is characterized by the sudden onset of malignant hypertension, acute kidney injury, and frequently microangiopathic hemolytic anemia (indicated by schistocytes and thrombocytopenia). The pathophysiology involves severe proliferation of the renal arcuate and interlobular arteries, leading to renal ischemia and massive activation of the renin-angiotensin-aldosterone system (RAAS). ACE inhibitors (such as short-acting oral captopril) are uniquely life-saving in SRC. Crucially, even though ACE inhibitors can typically worsen acute kidney injury, SRC is the major exception where they must be aggressively up-titrated to control blood pressure and reverse the primary disease process.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's history and vital signs.
A patient with diffuse cutaneous systemic sclerosis presents with malignant hypertension (225/125 mmHg), encephalopathy (headache, blurred vision, papilledema), and acute kidney injury (creatinine 3.4 mg/dL).
Recognizing the triad of systemic sclerosis, severe hypertension, and acute renal failure points directly to scleroderma renal crisis (SRC).
2
Evaluate the laboratory findings to confirm the diagnosis and rule out complications.
Labs show microangiopathic hemolytic anemia (schistocytes, thrombocytopenia, low hemoglobin) which frequently accompanies SRC due to endothelial injury. Acid-base status shows a fully compensated metabolic acidosis. Thyroid labs reflect euthyroid sick syndrome.
Confirming MAHA supports the severity of the vascular injury in SRC. The other laboratory abnormalities are secondary to the acute illness and AKI.
3
Determine the most critical pharmacologic intervention for this specific rheumatologic emergency.
Angiotensin-converting enzyme (ACE) inhibitors are the only therapy proven to reverse the profound renin-angiotensin-aldosterone system activation in SRC.
Unlike most other causes of AKI where ACE inhibitors are discontinued, SRC uniquely requires the prompt initiation and rapid titration of short-acting ACE inhibitors (like captopril) to prevent permanent renal failure and death.

Key Concept

Scleroderma renal crisis (SRC) presents with malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia in a patient with systemic sclerosis. The cornerstone of management is the immediate initiation of an ACE inhibitor.
Question 1720Question →

During routine rounding in the neonatal intensive care unit, a physician evaluates a male newborn delivered 6060 minutes ago via elective cesarean section at 3838 weeks of gestation. The mother's pregnancy was complicated by diet-controlled gestational diabetes. The infant, weighing 3,400 g3,400\text{ g}, had Apgar scores of 77 and 99 at 11 and 55 minutes, respectively. He was admitted to the unit for close monitoring due to increased work of breathing. Current vital signs show a temperature of 36.9∘C36.9^\circ\text{C} (98.4∘F98.4^\circ\text{F}), pulse of 158/min158/\text{min}, and respirations of 78/min78/\text{min}. He is maintaining an oxygen saturation of 94%94\% on continuous positive airway pressure (CPAP). Physical examination reveals mild intercostal retractions. Detailed skin inspection shows scattered, non-erythematous, superficial vesicles and small pustules over the chin, neck, and lower back. Several of these lesions have ruptured, leaving a collarette of scale surrounding a flat, hyperpigmented macule. Laboratory evaluation reveals a leukocyte count of 18,000/mm318,000/\text{mm}^3 with a normal differential. A Wright-stained smear of fluid from an intact pustule demonstrates numerous neutrophils and no bacteria. Chest radiography displays increased lung volumes, prominent perihilar vascular markings, and fluid in the minor fissure. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Continue continuous positive airway pressure and observation

Answer

Continue continuous positive airway pressure and observation
The correct approach is to continue continuous positive airway pressure and observation. The neonate's respiratory distress and radiographic findings (hyperinflation, prominent perihilar markings, fluid in fissures) following an elective cesarean section are diagnostic of Transient Tachypnea of the Newborn (TTN), which requires only supportive respiratory care (such as CPAP). The distinct skin findings—vesicles and pustules present at birth lacking an erythematous base, which rupture to leave hyperpigmented macules with a collarette of scale, alongside a smear showing neutrophils—are classic for Transient Neonatal Pustular Melanosis (TNPM). TNPM is a benign, self-resolving idiopathic condition requiring no dermatologic or systemic intervention.

Step-by-Step Solution

1
Analyze maternal history, delivery method, and respiratory signs.
The elective cesarean delivery, maternal gestational diabetes, immediate tachypnea, and characteristic chest radiograph (fluid in fissures, hyperinflation) strongly point to Transient Tachypnea of the Newborn (TTN).
Identifying the etiology of the respiratory distress is critical to determining if aggressive intervention is needed.
2
Evaluate the dermatologic findings and laboratory data.
Vesicles and pustules present at birth without erythema, rupturing to leave hyperpigmented macules with scale, combined with a neutrophilic smear, are diagnostic of Transient Neonatal Pustular Melanosis (TNPM). The leukocyte count of 18,000/mm³ is normal physiologic leukocytosis for a 1-hour-old neonate.
Differentiating a benign rash from an infectious one prevents unnecessary antibiotic or antiviral therapy.
3
Synthesize diagnoses to determine management.
The infant has two concurrent but distinct benign, self-limiting conditions: TTN and TNPM.
Since both conditions resolve on their own without pharmacologic intervention, supportive respiratory care is the only indicated step.

Key Concept

Differentiating benign neonatal skin conditions (e.g., TNPM) and self-limited respiratory issues (e.g., TTN) from infectious or severe pulmonary etiologies to avoid unnecessary pharmacologic interventions.
Estimated Time:1m 30s
PreviousPage 86 / 414Next
All practice questions — USMLE Step 2 CK | Examkin